Astrazeneka should concede that Inovio has a much better vaccine product with INO-4800. They should offer Inovio a $100 pps to buy them out and converge the two Cos into one. We all know its all biased now because the government is in bed with Astrazeneka officials and will give them anything if their lousy and dangerous vaccine appears to make it out of the starting gate. Inovio's INO-4800 is the golden vaccine that will be the one of choice by many doctors, and hospitals and institutions. Its all a matter of time before the world realizes what we have here. I would not be surprised to see INO stock trade at $500 pps without any reverse split in the coming year or so.
News 
Market Data 
Discover 
AI
